Mads Hvid Poulsen (M H Poulsen, Mads H A Poulsen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

BJU international

BJUI compass

Scandinavian journal of urology

Research and reports in urology

University of Southern Denmark

University of Southern Denmark (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Southern Denmark

Denmark

Associate Professor :: Institute of Clinical Research

Odense Universitetshospital

Denmark

Staff Specialist :: Urology

Education History

University of Southern Denmark

Denmark

PHD

Publications

Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Aksnessæther, Maiju Pesonen, Kristian Thon, Torgrim Tandstad, Teemu Murtola, Mads Hvid Poulsen, Tobias Nordström, Maria Nyre Vigmostad, Fredrik Ottosson, Karin Holmsten, Ola Christiansen, Marit Slaaen, Erik Skaaheim Haug, Anne Holck Storås, Lars Asphaug, Antti Sakari Rannikko, Klaus Brasso, null null
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P). BJU international 133 (6) (2024)
Nicolai Skov Schiellerup, Hanne Kobberø, Karin Andersen, Charlotte Aaberg Poulsen, Mads Hvid Poulsen
Evaluation of Botox treatment in patients with chronic scrotal pain: Protocol for a randomized double-blinded control trial. BJUI compass 5 (6) (2024)
Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Aksnessaether, Maiju Pesonen, Kristian Thon, Torgrim Tandstad, Teemu Murtola, Mads Hvid Poulsen, Tobias Nordström, Maria Nyre Vigmostad, Fredrik Ottosson, Karin Holmsten, Ola Christiansen, Marit Slaaen, Erik Skaaheim Haug, Anne Holck Storås, Lars Asphaug, Antti Sakari Rannikko, Klaus Brasso, null null
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P). BJU international (2024)
Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Aksnessæther, Maiju Pesonen, Kristian Thon, Torgrim Tandstad, Teemu Murtola, Mads Hvid Poulsen, Tobias Nordström, Maria Nyre Vigmostad, Fredrik Ottosson, Karin Holmsten, Ola Christiansen, Marit Slaaen, Erik Skaaheim Haug, Anne Holck Storås, Lars Asphaug, Antti Sakari Rannikko, Klaus Brasso, null null
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P). BJU international 133 (6) (2024)
Nicolai Skov Schiellerup, Hanne Kobberø, Karin Andersen, Charlotte Aaberg Poulsen, Mads Hvid Poulsen
Evaluation of Botox treatment in patients with chronic scrotal pain: Protocol for a randomized double-blinded control trial. BJUI compass 5 (6) (2024)
Karen Middelbo Buch-Olsen, Mads Hvid Poulsen, Steinbjørn Hansen, Mie Holm Vilstrup, Jorun Holm, Soren Hess, Paw Christian Holdgaard, Karsten Egbert Arnold Zieger, Søren Sørensen Madsen, Oke Gerke, Kasper Tholstrup Pedersen, Johan Hygum Dam, Niels Langkjaer, Louise Dorner Østergaard, Jon Thor Asmussen, Poul-Erik Braad, Birgitte Noergaard, Matthias Eiber, Malene Grubbe Hildebrandt
A randomised trial of [ 18 F]PSMA-1007-PET/CT versus NaF-PET/CT for staging primary prostate cancer: A trial protocol. BJUI compass 4 (5) (2023)
Hanne Kobberø, Margrethe Andersen, Karin Andersen, Torben Brøchner Pedersen, Mads Hvid Poulsen
Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital. Scandinavian journal of urology (2022)
Martin Lund, Torben Brøchner Pedersen, Søren Feddersen, Louise Dorner Østergaard, Charlotte A Poulsen, Christian Enggaard, Mads Hvid Poulsen, Lars Lund
Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer. Research and reports in urology 14 (2022)
Rasmus Sã Gaard Hansen, Signe Hedengran Biørn, Johan Baden Birk-Korch, Søren Paludan Sheikh, Mads Hvid Poulsen, Pernille Just Vinholt
Prevalence of prostate cancer in men with haematuria: a systematic review and meta-analysis. BJU international (2022)
Rasmus Sã Gaard Hansen, Signe Hedengran Biørn, Johan Baden Birk-Korch, Søren Paludan Sheikh, Mads Hvid Poulsen, Pernille Just Vinholt
Prevalence of prostate cancer in men with haematuria: A systematic review and meta-analysis. BJU international (2022)
Karin Andersen, Hanne Kobberø, Torben Brøchner Pedersen, Mads Hvid Poulsen
Percutaneous tibial nerve stimulation for idiopathic and neurogenic overactive bladder dysfunction: a four-year follow-up single-centre experience. Scandinavian journal of urology 55 (2) (2021)
Pablo Borrelli, Måns Larsson, Johannes Ulén, Olof Enqvist, Elin Trägårdh, Mads Hvid Poulsen, Mike Allan Mortensen, Henrik Kjölhede, Poul Flemming Høilund-Carlsen, Lars Edenbrandt
Artificial intelligence-based detection of lymph node metastases by PET/CT predicts prostate cancer-specific survival. Clinical physiology and functional imaging 41 (1) (2020)
Eik Dybboe Bjerre, Thomas Hindborg Petersen, Anders Bojer Jørgensen, Christoffer Johansen, Peter Krustrup, Bente Lomholt Langdahl, Mads Hvid Poulsen, Søren Sørensen Madsen, Peter Busch Østergren, Michael Borre, Mikael Rørth, Klaus Brasso, Julie Midtgaard Klausen
Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial. PLoS medicine 16 (10) (2019)

Mads Hvid Poulsen.css-eqlu8i{font-size:small;padding-left:4px;} (M H Poulsen, Mads H A Poulsen)

Publication Activity (10 Years)

Top Topics

Top Venues

Mads Hvid Poulsen (M H Poulsen, Mads H A Poulsen)